BioArctic: Interim Report for the period April - June 2026

EarningsLeqembiPositive

AI Analysis

Summary

BioArctic released interim report for Q2 2026 with Eisai providing sales forecast for Leqembi of JPY 143.5 billion for fiscal year 2026-2027. New approvals and additional strategic partnerships were noted during the period.

Financial Highlights

Guidance

JPY 143.5 billion forecasted sales for Leqembi (Eisai fiscal year April 2026 to March 2027)

Importance:5/10

Sentiment:

0.60

interim reportLeqembisales forecaststrategic partnershipsQ2 2026

Related Companies

$BIOA-B.ST $ESALY

Read the original article

Published by PR Newswire Pharma on August 26, 2026 6:46 AM

Read Original